| ID | 119037 |
| 著者 |
Okada, M
Sakamoto Hospital
Iwatsuki, N
Sakamoto Hospital
Sakamoto, K
Sakamoto Hospital
Ogawa, T
Sakamoto Hospital
|
| キーワード | Super-Low Carbohydrate Diet (LCD)
Oral Semaglutide (Rybelsus)
Glucagon-Like-Peptide 1 Receptor Agonist (GLP1-RA)
Sodium N-(8-[2-hydroxybenzoyl] amino) Caprylate (SNAC)
|
| 資料タイプ |
学術雑誌論文
|
| 抄録 | Background: Oral semaglutide (Rybelsus) has been in focus as glucagon-like-peptide 1 receptor agonist (GLP1-RA).
Case presentation: Patient is 40-year-old male with diagnosed as type 2 diabetes (T2D). He complained of blurred vision in April 2022, and showed HbA1c 12.0%. He was transferred to university hospital for ophthalmic operation of proliferative vitreoretinopathy and our clinic for diabetic control. He was initiated Rybelsus 3mg/day and super-low carbohydrate diet (LCD) associated with normalized glucose profile in short period. Discussion: This case showed satisfactory clinical efficacy for HbA1c 8.7% and 6.6% in 4 and 8 weeks, and weight reduction 6kg for 3 months. |
| 掲載誌名 |
International Journal of Case Reports and Clinical Images
|
| ISSN | 26943816
|
| 出版者 | Pubtexto Publishers
|
| 巻 | 4
|
| 号 | 3
|
| 開始ページ | 184
|
| 発行日 | 2022-08-08
|
| 権利情報 | This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
|
| 出版社版DOI | |
| 出版社版URL | |
| フルテキストファイル | |
| 言語 |
eng
|
| 著者版フラグ |
出版社版
|
| 部局 |
医学系
|
